Gilead Sciences readies offering of three fixed-rate senior notes

Chicago, Sept. 7 – Gilead Sciences, Inc. plans to price an offering of three fixed-rate notes, according to a 424B5 filing with the Securities and Exchange Commission on Thursday morning.

Each of the notes will be callable early with a make-whole premium until a number of months before each maturity date when they will be callable at par.

If there is any change-of-control triggering event, Gilead will make an offer to purchase the notes at 101.

Barclays and Citigroup Global Markets Inc. are joint bookrunners.

Computershare Trust Co., NA will be the trustee.

Davis Polk & Wardwell LLP is advising the issuer. Latham & Watkins LLP is working as counsel for the underwriters.

Proceeds will be used for general corporate purposes.

The research-based biopharmaceutical company is based in Foster City, Calif.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.